Logo image of HHLA

HH&L ACQUISITION CO -CLASS A (HHLA) Stock News

NYSE:HHLA - New York Stock Exchange, Inc. - KYG397141030 - Common Stock - Currency: USD

10.75  -0.03 (-0.23%)

HHLA Latest News, Press Relases and Analysis

News Image
2 years ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday.

Mentions: APAC CMCA BMAC BLUA ...

News Image
2 years ago - Seeking Alpha

SPAC HH&L terminates merger with diagnostics developer DiaCarta (NYSE:HHLA)

Hong Kong-based SPAC HH&L (HHLA) said in a filing that it has terminated its planned merger with liquid biopsy developer DiaCarta. Read more here.

News Image
2 years ago - DiaCarta, Ltd.

DiaCarta Receives Accreditation by the College of American Pathologists (CAP)

PLEASNTON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a novel molecular diagnostic test developer for cancer and infectious...

News Image
2 years ago - DiaCarta, Ltd.

DiaCarta Announces Five Abstracts Accepted for Presentation at AACR Annual Meeting 2023

Abstracts demonstrating XNA technology’s improvements to assay sensitivity across different technology platforms and support for use in companion...

News Image
2 years ago - DiaCarta, Ltd.

DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit

PLEASANTON, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced that the...

News Image
2 years ago - DiaCarta, Ltd.; Nonagen Bioscience

DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience

DiaCarta Starts to Receive Samples for Oncuria® Bladder Cancer Test at its CLIA Lab PLEASANTON, Calif. and LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE)...